PPT-25 YEARS OF AKT - AN EVALUATION OF ITS FUNCTION IN CELL SURVIVAL AND CANCER

PROF V LAKSHMIPATHI PROF Retd CELL BIOLOGY ampENZYMOLOGY KAKATIYA UNIVERSITY WARANGAL506009 Email lvadlakondagmailcom MY FORAYS INTO CELL SIGNALING STARTED TWO YEARS AFTER . e-portfolio update. Feb. 2012. Came into effect from 2011. Clinical encounters: . At least 3 per month . Professional conversations: . No minimum but should include all meetings with supervisors, and any complaints or feedback. SURVIVAL 101 SURVIVAL the Heart . f. rom . Ischemia . and . Reperfusion Injury . via . PI3K/. Akt. /. eNOS. Pathway. Yan Wu, . Xiangru. Lu, . Fuli. Xiang, and . Qingping. . Feng. Background. Ischemic Heart Disease (IHD). Paul . Sieber. MD FACS. Lancaster Urology. ADT Clinic. Why . 1. Consistency of care . . 2. Improved outcomes. . 3. Better economics. What does it take. 1. Discipline. Ruth Etzioni. Roman Gulati . Lurdes . inouE. Dhamanpreet. Kaur. Fred Hutchinson cancer research center. TODAY’S PRESENTATION. Trends in prostate cancer incidence and mortality. What are the trends really telling us? A mathematical model. Wilhelmina Ross, . PA, MPH, CTR - Westat. Jeannette Jackson-Thompson. , MSPH, PHD n- . Missouri Cancer Registry and Research Center . Diane . Ng, MPH, . Westat . Maricarmen . Traverso-Ortiz, MPH, CTR - . PGY-6. Pulmonary and Critical Care Fellow . GOALS. Lung Cancer Incidence & Mortality . Dealing with Incidental Found Nodules. You are responsible for all ED “un” necessary imaging . Lung . Cancer . 6038 Journal of Cancer 6038doi: 10.7150/jcaResearch PaperSurfactin from Bacillus subtilisattenuates ambient air particulate matterpromoted human oral cancer cells metastatic potential ThiThuy Tien VoC Reasons why lung cancer survival is still variable and poor?. Late presentation . Deprivation (not just smoking, but mainly). Lack of advocacy & research. Stigma. Access to staff,diagnostics and treatment. Murphy EL, Wang B, Sacher RA, Fridey J, Smith JW, Nass CC, et al. Respiratory and Urinary Tract Infections, Arthritis, and Asthma Associated with HTLV-I and HTLV-II Infection. Emerg Infect Dis. 2004;10(1):109-116. https://doi.org/10.3201/eid1001.020714. 5 YEAR, AGE-STANDARDISED, 2000-2007. In line with incidence, cancer mortality has also increased over the past two decades although at a slower pace. For some countries cancer mortality rates are even declining.. a collaboration between PHE and ONS. John Broggio, Cancer Analytical Lead. What is cancer survival?. . 2. Cancer survival in England - John Broggio. A statistic that measures the mortality of cancer patients compared to the mortality of the general population . 233 sat, 165 passed – 71% overall. Pass mark was 70.5%. 29% sitters got above 80%, (8 of those >90%). 68 failed and 33 of these were within 5%.. 2 trainees on 6. th. and 7. th. attempts both passed. 1. Access and treatment for cancer outline . 2. Cancer diagnosed as an emergency in London. Variation . Types of treatment (breast cancer). Variation in bowel cancer outcomes. Variation in lung cancer outcomes .